And it shouldn't come as a surprise that the past week has been one of the busiest ever, based on number of visitors.
It probably also shouldn't be a surprise that the number one visitor was Pfizer. Close to 10,000 visits in a week. Wow. Seems like everyone must talk about the India affair and the maraviroc premarketing allegations over at Big Blue.
But what about the rest, who else cared about my Pfizer stories?
Some interesting stuff there. Lot's of biotech companies doing deals with Pfizer. I guess they may realize that Pfizer is spying on them too. Also some major Pfizer competitors, especially Merck. And many investment companies and hedge funds. Among the big ones, Merrill Lynch keeps coming back, over and over. And, of course, some of the companies Pfizer spied on in India are coming by.
Oh, and the International Trade Administration of the Department of Commerce seems to have taken a keen interest in the Pfizer India affair. They promote U.S. trade. Maybe they felt Pfizer's behavior in India was an embarrassment to the United States.
And, as always, the Department of Justice and the Department of Health and Human Services are visiting. Actually, lot's of visits by the Department of Health and Human Services, but I only show one of them below (click on images to see full size).
But no one stayed longer than two visitors - Institutional Investor and the law firm Davis, Polk & Wardwell . They stayed on my blog for over a day.
Davis, Polk & Wardwell is a law firm working for Pfizer, which has interviewed many Pfizer employees. Davis Polk ranked first among all U.S. law firms in a survey in which Fortune 250 law departments were asked to name the firms they rely on most in corporate transactions. They have a long history of representing institutions in complex criminal cases. Their white collar criminal practice includes the former U.S. Attorney for the Southern District of New York. They focus on advising clients in internal investigations, grand jury investigations and violations of the Foreign Corrupt Practices Act. Sounds like Pfizer came to the right place.
Most surprising of all, I think Pfizer CEO Jeff Kindler came by. Can't be 100% sure. It's been a long time since he was here. But I really think it was him . . . click on image.
I'm honored by the attention.
And the week is far from over.
Tomorrow we'll take a look at what Pfizer is doing with its most recent whistleblower and communication with the OIG.
Friday we'll check out the unusual Mea Culpa by a Pfizer lawyer.
It'll be an amazing week.
6 comments:
Yahooo maybe Jeff has old emails he wants to share...step right on in big guy the water is fine and Peter is the best....
Best regards,
Jane Roe
Doc, if you have the info re visitors that you can share, I would like the list of all the copetitors or should we say all the other bigharma companies. They mybe interested for may reasons including educating themselves as to what they should and should not do in their own cases, should the worse hapen.
Many thanks in advance.
Doc, you've truly outdone yourself in the past week and a half. This is one of the coolest things I've ever seen happen-- and the high profile departments and figures paying attention to it is quite amazing!
To see Forbes report the CFO's sudden departure (but with little real explanation as to why) and then to come over to your site and see the full "poop" behind the departure-- priceless.
I'm excited that there's yet even more to come-- should be quite interesting indeed.
Move over you clowns at the Washington Post and New York Times, we've finally got someone who really knows how to crack a case and do investigative reporting!!!
When will we expose the even more sinister case of big pharma and buddies hiding the fact that advancing PATERNAL age is the cause of de novo diabetes, cancers, Alzheimer's, Crohn's, autism, schizophrenia, MS, many other of the "mysterious" non-familial genetic disorders whose rates have been climbing with increasing average paternal age. How has big pharma hid this information for over 50 years and laughed all the way to the bank as the illnesses of the offspring of those ignorant of the serious mutations accumulating in men's ancestral spermatogonia, as young as 33-35, swell the markets for their medications? This is also as yet an untold story.
Peter, I visit your blog regularly because it's the only way I can find out what my senior staff are up to. I certain can't expect them to tell me the truth, can I? After all, if they did, I'd fire them...
To jeffrey b kindler. You maybe jeffrey but you ain't the real kindler. The real one would neve make a comment like this. He knows the rule; Omerta, no comments, no admittions no denial no nothing. He has not come up the big pharma's food chain to make a naive mistake like this. I might be wrong, but doubt it. Only doc would know and if it were the true "snake charmer" he would have told us.
Am I right doc?
Post a Comment